Oestreicher J H, Liu E, Berkowitz M
Department of Ophthalmology, University of Toronto, Canada.
Ophthalmology. 1997 Feb;104(2):324-9. doi: 10.1016/s0161-6420(97)30316-9.
The authors analyzed all the complications associates with the first 100 hydroxyapatite orbital implants performed by one surgeon, and compare scleral wrapping versus Dexon mesh (polyglycolic acid, Davis & Geck, Manati, Puerto Rico) wrapping in light of these complications.
Prior studies have not included the full range of complications that can occur with hydroxyapatite orbital implants. Dexon mesh implant wrapping is a promising substitute for sclera and avoids the risks involved in using donor tissue.
A retrospective analysis of 100 consecutive cases was performed.
Many minor complications occurred, but the rate of exposure was low (3%) and no implant was lost. Dexon mesh wrapping was similar to scleral wrapping with respect to complications, although more posterior implant placement was necessary to avoid exposure in the Dexon-wrapped group.
Surgeons and patients must be prepared for many minor complications when using hydroxyapatite orbital implants, but these can be readily overcome. Dexon mesh wrapping of the implant is recommended to avoid using donor tissue.
作者分析了由一位外科医生实施的前100例羟基磷灰石眼眶植入术的所有相关并发症，并根据这些并发症比较巩膜包裹与 Dexon 网（聚乙醇酸，Davis & Geck，马纳蒂，波多黎各）包裹的情况。
先前的研究并未涵盖羟基磷灰石眼眶植入术可能出现的所有并发症。Dexon 网植入物包裹是巩膜的一种有前景的替代方法，可避免使用供体组织的风险。
对连续100例病例进行回顾性分析。
出现了许多轻微并发症，但暴露率较低（3%），且无植入物丢失。在并发症方面，Dexon 网包裹与巩膜包裹相似，尽管在 Dexon 网包裹组中需要更靠后的植入位置以避免暴露。
使用羟基磷灰石眼眶植入物时，外科医生和患者必须为许多轻微并发症做好准备，但这些并发症很容易克服。建议对植入物采用 Dexon 网包裹以避免使用供体组织。
